Paper35658124
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL.
Xia M and 18 others. Cancer Discov, 2022. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL. Papers, record 35658124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35658124
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B-Cell CLL-Lymphoma 10 Protein | Major topic |
| Lymphoma, Large B-Cell, Diffuse | Major topic |
| CARD Signaling Adaptor Proteins | |
| Guanylate Cyclase | |
| Humans | |
| Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein | |
| Mutation | |
| Signal Transduction |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R35 CA220499 | NCI NIH HHS | United States | R35CA220499 | PubMed and NIH | NIH RePORTER |
| R01 CA249843 | NCI NIH HHS | United States | R01CA249843 | PubMed and NIH | NIH RePORTER |
| P50 CA192937 | NCI NIH HHS | United States | P50CA192937 | PubMed | NIH RePORTER |
| R01 CA182736 | NCI NIH HHS | United States | R01CA182736 | PubMed and NIH | NIH RePORTER |
| U24 GM129547 | NIGMS NIH HHS | United States | U24GM129547 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 35929131 | BCL10 Mutants: Architects of Oncogenic Signaling Provide a Blueprint for Precision Medicine. | https://conductscience.org/library/papers/35929131 |
Source PubMed
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29713087 | Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. | Nat Med | 2018 | https://conductscience.org/library/papers/29713087 | PubMed |
| 2 | 10187815 | mE10, a novel caspase recruitment domain-containing proapoptotic molecule. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10187815 | PubMed |
| 3 | 32289277 | A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications. | Cancer Cell | 2020 | https://conductscience.org/library/papers/32289277 | PubMed |
| 4 | 26193343 | Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma. | Nat Med | 2015 | https://conductscience.org/library/papers/26193343 | PubMed |
| 5 | 23149938 | A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival. | Mol Cell Biol | 2013 | https://conductscience.org/library/papers/23149938 | PubMed |
| 6 | 20054396 | Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. | Nature | 2010 | https://conductscience.org/library/papers/20054396 | PubMed |
| 7 | 23046132 | Sensing of microbial molecular patterns by Toll-like receptors. | Immunol Rev | 2012 | https://conductscience.org/library/papers/23046132 | PubMed |
| 8 | 32012328 | High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. | Hematol Oncol | 2020 | https://conductscience.org/library/papers/32012328 | PubMed |
| 9 | 18323416 | Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. | Science | 2008 | https://conductscience.org/library/papers/18323416 | PubMed |
| 10 | 24869598 | Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib. | N Engl J Med | 2014 | https://conductscience.org/library/papers/24869598 | PubMed |
| 11 | 27135977 | Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies. | Curr Opin Hematol | 2016 | https://conductscience.org/library/papers/27135977 | PubMed |
| 12 | 25805587 | B-cell receptor signaling in diffuse large B-cell lymphoma. | Semin Hematol | 2015 | https://conductscience.org/library/papers/25805587 | PubMed |
| 13 | 34014917 | Signaling through polymerization and degradation: Analysis and simulations of T cell activation mediated by Bcl10. | PLoS Comput Biol | 2021 | https://conductscience.org/library/papers/34014917 | PubMed |
| 14 | 12560219 | MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. | Blood | 2003 | https://conductscience.org/library/papers/12560219 | PubMed |
| 15 | 10676951 | Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. | Nature | 2000 | https://conductscience.org/library/papers/10676951 | PubMed |
| 16 | 24878341 | Parts, assembly and operation of the RIG-I family of motors. | Curr Opin Struct Biol | 2014 | https://conductscience.org/library/papers/24878341 | PubMed |
| 17 | 15264254 | UCSF Chimera--a visualization system for exploratory research and analysis. | J Comput Chem | 2004 | https://conductscience.org/library/papers/15264254 | PubMed |
| 18 | 24491438 | Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms. | Cancer Discov | 2014 | https://conductscience.org/library/papers/24491438 | PubMed |
| 19 | 22658522 | Selective autophagy of the adaptor protein Bcl10 modulates T cell receptor activation of NF-κB. | Immunity | 2012 | https://conductscience.org/library/papers/22658522 | PubMed |
| 20 | 29641966 | Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29641966 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42852632 | Resistance to covalent Bruton's tyrosine kinase inhibitors in diffuse large B‑cell lymphoma: Molecular mechanisms and therapeutic implications (Review). | Int J Oncol | 2026 | https://conductscience.org/library/papers/42852632 | PubMed |
| 42487683 | Molecular Pathogenesis and Therapeutic Response of Diffuse Large B Cell Lymphoma Genetic Subtypes. | Annu Rev Cancer Biol | 2026 | https://conductscience.org/library/papers/42487683 | PubMed |
| 41783325 | Therapeutic targeting of MALT1 in oncology: Mechanism, inhibitor development, and clinical prospects. | J Cell Commun Signal | 2026 | https://conductscience.org/library/papers/41783325 | PubMed |
| 41466145 | T follicular helper cells transiently unlock a plasticity state in germinal centre B cells during the humoral immune response. | Nat Cell Biol | 2026 | https://conductscience.org/library/papers/41466145 | PubMed |
| 41332868 | Analysis and Interpretation of Somatic NMD-Escaping Variants in Oncogenes and Dual-Function Genes across Adult and Pediatric Cancer Cohorts. | medRxiv | 2025 | https://conductscience.org/library/papers/41332868 | PubMed |
| 40779122 | Emodin Alleviates Sepsis-Induced Multiorgan Damage by Inhibiting NETosis through Targeting Neutrophils BCL-10. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40779122 | PubMed |
| 40775128 | Decoding NF-κB: nucleocytoplasmic shuttling dynamics, synthetic modulation and post-therapeutic behavior in cancer. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/40775128 | PubMed |
| 40453079 | Strategies for CRISPR-based knock-ins in primary human B cells and lymphoma cell lines. | Front Immunol | 2025 | https://conductscience.org/library/papers/40453079 | PubMed |
| 40231473 | A small-molecule inhibitor of BCL10-MALT1 interaction abrogates progression of diffuse large B cell lymphoma. | J Clin Invest | 2025 | https://conductscience.org/library/papers/40231473 | PubMed |
| 40090010 | Blunted CD40-responsive enhancer activation in CREBBP-mutant lymphomas can be restored by enforced CD4 T-cell engagement. | Blood | 2025 | https://conductscience.org/library/papers/40090010 | PubMed |
| 39977327 | A structural atlas of death domain fold proteins reveals their versatile roles in biology and function. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/39977327 | PubMed |
| 39894894 | Bruton's tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven by BCL10 gain-of-function mutants to venetoclax. | Blood Cancer J | 2025 | https://conductscience.org/library/papers/39894894 | PubMed |
| 39853274 | Audit of B-cell cancer genes. | Blood Adv | 2025 | https://conductscience.org/library/papers/39853274 | PubMed |
| 39512504 | Biomarker potential of nuclear Nrf2 activation in the ABC subtype of diffuse large B‑cell lymphoma. | Oncol Lett | 2025 | https://conductscience.org/library/papers/39512504 | PubMed |
| 39227959 | Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy. | Biomark Res | 2024 | https://conductscience.org/library/papers/39227959 | PubMed |
| 38906964 | First-in-class inhibitor of HSP110 blocks BCR activation through SYK phosphorylation in diffuse large B-cell lymphoma. | Leukemia | 2024 | https://conductscience.org/library/papers/38906964 | PubMed |
| 38662551 | TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38662551 | PubMed |
| 38507740 | Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma. | Mol Cancer Ther | 2024 | https://conductscience.org/library/papers/38507740 | PubMed |
| 38458187 | ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis. | Cancer Cell | 2024 | https://conductscience.org/library/papers/38458187 | PubMed |
| 37767562 | Profiling the activity of the para-caspase MALT1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application. | Haematologica | 2024 | https://conductscience.org/library/papers/37767562 | PubMed |
Genes24
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35658124
GET https://conductscience.org/api/papers/v1/35658124/references?page=2